Výsledky vyhledávání - "Karl Mettinger"

Supplementary Figure Legends 1-3 from Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies

Autor: Kevin J. Harrington, John Chester, Alan A. Melcher, Geoff D. Hall, Hardev S. Pandha, Richard G. Vile, Karl Mettinger, Brad Thompson, Matt Coffey, Konstantinos N. Syrigos, James Larkin, Martin E. Gore, Kate Newbold, Chris Nutting, MaryAnne Tanay, Mercel Ball, Katie Twigger, Victoria Roulstone, Eleni M. Karapanagiotou

PDF file - 48K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14472fe566c12d44682a8eea19bcd8dd
https://doi.org/10.1158/1078-0432.22445160.v1

Zobrazit plný text záznamu

Supplementary Figure 1 from Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies

PDF file - 48K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e014b24683052a7b99f88a940a54727
https://doi.org/10.1158/1078-0432.22445169.v1

Zobrazit plný text záznamu

Supplementary Figure 2 from Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies

PDF file - 43K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817669f75d3b5720f4681fb3d6155c88
https://doi.org/10.1158/1078-0432.22445166.v1

Zobrazit plný text záznamu

Supplementary Figure 3 from Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies

PDF file - 267K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c35d37e05e0127476c1ea0b1808a9a
https://doi.org/10.1158/1078-0432.22445163.v1

Zobrazit plný text záznamu

Data from Phase I/II Trial of Carboplatin and Paclitaxel Chemotherapy in Combination with Intravenous Oncolytic Reovirus in Patients with Advanced Malignancies

Purpose: Reovirus type 3 Dearing (RT3D) replicates preferentially in Ras-activated cancers. RT3D shows synergistic in vitro cytotoxicity in combination with platins and taxanes. The purpose of this phase I/II study was to assess RT3D combined with ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b5df04b475d012cc8af0b7476602cd
https://doi.org/10.1158/1078-0432.c.6520401

Zobrazit plný text záznamu

Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma

Autor: Anil Tulpule, Parkash S. Gill, Alvin Friedman-Kien, Lily Mantelle, Carlos Garces, Jerome Groopman, M. Wayne Saville, William Harrington, Karl Mettinger, David T. Scadden, M A B Byron Espina

Publikováno v: Cancer. 95(1)

BACKGROUND Treatment options are limited for patients with advanced acquired immunodeficieny syndrome (AIDS)-related Kaposi sarcoma (AIDS-KS) whose disease has progressed after receiving therapy with liposomal anthracyclines or combination chemothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97b810c5c56045bc877b183db2c62c09
https://pubmed.ncbi.nlm.nih.gov/12115328

Zobrazit plný text záznamu

First Report of the Phase III North American Trial of Decitabine in Advanced Myelodysplastic Syndrome (MDS)

Autor: Jean Pierre J. Issa, Virginia M. Klimek, Hussain I. Saba, Azra Raza, Karl Mettinger, Craig S. Rosenfeld, James L. Slack, John F. DiPersio, Hagop M. Kantarjian, Carlos M. de Castro

Publikováno v: Blood. 104:67-67

MDS is a disease of the elderly marked by dysplasia of hematopoetic cell lines resulting in cytopenias and AML progression. There is currently no treatment approved to alter the natural history of the disease. Aberrant methylation associated with can

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::323021c3db3b9e426d7702c9dbd84b8d
https://doi.org/10.1182/blood.v104.11.67.67

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání